G2G-24370-12863
2 vaccinations
12 coded responses
14 check-ins
12 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 917 / CA
- Registered
- 2021-03-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-02-23
Dose 1 — Pfizer-BioNTech
-
2021-03-16
Dose 2 — Pfizer-BioNTech
-
2021-03-17
Registered in v-safe
-
2021-03-17
Survey response — days 1–6 daily, dose 2MedDRA: Hypopnoea — Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activitiesFree text: Breathing is shallowMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-18
Survey response — days 1–6 daily, dose 2MedDRA: Rhinorrhoea, Sinus congestion — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tirednessFree text: Runny nose and sinus congestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-19
Survey response — days 1–6 daily, dose 2MedDRA: Rhinorrhoea — Feeling: Fair · Site: Pain · Headache, Joint pains, Fatigue or tirednessFree text: Severe runny noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-20
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Itching · Muscle or body aches, Rash, not including the immediate area around the injection siteAdult check-in
-
2021-03-21
Survey response — days 1–6 daily, dose 2MedDRA: Rhinorrhoea, Sinus disorder — Feeling: Good · Fatigue or tiredness, Rash, not including the immediate area around the injection siteFree text: Sinus and runny noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-22
Survey response — days 1–6 daily, dose 2MedDRA: Sinus disorder — Feeling: Good · Rash, not including the immediate area around the injection siteFree text: Sinus issues remainMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-23
Survey response — day 7, dose 2MedDRA: Paranasal sinus hypersecretion — Feeling: Fair · Site: Pain, Itching · Rash, not including the immediate area around the injection siteFree text: Sinus issues/drainageMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-30
-
2021-04-06
Survey response — day 21, dose 2MedDRA: COVID-19, Office visit, Rash — Feeling: Fair · Get care from a doctor or other healthcare professionalFree text: Symptoms: My rashes that started with COVID continue.I now have to use steroid cream. · Healthcare visit (other): Office visitMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-06
Report sent to call center — day 21, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-04-13
Survey response — day 28, dose 2MedDRA: Office visit, Rash, Self-medication, Sinus disorder — Feeling: Good · Get care from a doctor or other healthcare professional · HospitalizationFree text: Symptoms: My immune system is still fighting hard. Im still experiencing skin rashes and sinus issues. Quite severe to the point where Im now using steroid cream for the skin issues and daily decongestant and antihistamines. · Healthcare visit (other): Office visitMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-13
Report sent to call center — day 28, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-04-21
Survey response — day 35, dose 2MedDRA: Rash — Feeling: GoodFree text: Rash continuesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-27
Survey response — day 42, dose 2MedDRA: Rash — Feeling: GoodFree text: Skin rashes continue unabated.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-15
Survey response — 3 months, dose 2MedDRA: Arthralgia, Joint swelling, Pain in extremity, Peripheral swelling, Skin discomfort, Skin disorder — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Swollen ankles and fingers. Fingers hurt.Skin issues continue.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-11-06
-
2022-03-16
Survey response — 12 months, dose 2MedDRA: COVID-19, Rash, Skin irritation — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Skin rashes and irritation flare up. This condition started when I had Covid-19 and I have never fully recovered.MedDRA releases: 2024-11 · check-in free text available
-
2022-03-16
Report sent to call center — 12 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-03-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-23 | Pfizer-BioNTech | |
| 2 | 2021-03-16 | Pfizer-BioNTech |
Call center
3 call center cases
3 unsuccessful
1 wait over 3 months for a first call
Free text
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): Breathing is shallow
Systemic reaction (other): Runny nose and sinus congestion
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Severe runny nose
Systemic reaction (other): Sinus and runny nose
Systemic reaction (other): Sinus issues remain
Release 6 — day 7, dose 2
Systemic reaction (other): Sinus issues/drainage
Release 7 — day 21, dose 2
Symptoms: My rashes that started with COVID continue.I now have to use steroid cream.
Healthcare visit (other): Office visit
Release 7 — day 28, dose 2
Symptoms: My immune system is still fighting hard. Im still experiencing skin rashes and sinus issues. Quite severe to the point where Im now using steroid cream for the skin issues and daily decongestant and antihistamines.
Healthcare visit (other): Office visit
Release 7 — day 35, dose 2
Symptoms: Rash continues
Release 8 — day 42, dose 2
Symptoms: Skin rashes continue unabated.
Release 9 — 3 months, dose 2
Symptoms: Swollen ankles and fingers. Fingers hurt.Skin issues continue.
Release 11 — 12 months, dose 2
Symptoms: Skin rashes and irritation flare up. This condition started when I had Covid-19 and I have never fully recovered.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| SD | Arthralgia | ✓ | ✓ | ○ |
| SD | COVID-19 | ✓ | ✓ | ✓ |
| SD | Joint swelling | ✓ | ✓ | ✓ |
| SD | Pain in extremity | · | · | ✓ |
| SD | Peripheral swelling | ✓ | ✓ | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SD | Self-medication | ✓ | ✓ | ✓ |
| SD | Sinus disorder | ✓ | ✓ | ✓ |
| SD | Skin discomfort | ✓ | ✓ | ○ |
| SD | Skin disorder | · | · | ✓ |
| SD | Skin irritation | · | · | ✓ |
| SRO | Hypopnoea | ✓ | ✓ | ✓ |
| SRO | Paranasal sinus hypersecretion | ✓ | ✓ | ✓ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
| SRO | Sinus congestion | ✓ | ✓ | ✓ |
| SRO | Sinus disorder | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release